Xiebai Powder combined with azithromycin may play a role in the treatment of pneumonia through the IL-17 signaling pathway, tumor necrosis factor signaling pathway, c-type lectin receptor signaling pathway, Toll-like receptor signaling pathway, and HIF-1 signaling pathway. Here, IL17A is linked to susceptibility to pneumonia measurement.